1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Documented Her2 Overexpression: new trials by email Literature Review of Documented Her2 Overexpression trials Research Report on Documented Her2 Overexpression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets MM-302, Trastuzumab - Brain Metastases, Documented Her2 Overexpression | Early Phase 1 | Withdrawn | Pamela Munster | 2016-04-01 | 2017-05-04 |
Brain Neoplasms (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1)
Trastuzumab (1) · gancotamab (1)
Pamela Munster (1)